Literature DB >> 11306050

Selective protection by stably transfected human ALDH3A1 (but not human ALDH1A1) against toxicity of aliphatic aldehydes in V79 cells.

A J Townsend1, S Leone-Kabler, R L Haynes, Y Wu, L Szweda, K D Bunting.   

Abstract

Toxic medium chain length alkanals, alkenals, and 4-hydroxyalkenals that are generated during lipid peroxidation are potential substrates for aldehyde dehydrogenase (ALDH) isoforms. We have developed transgenic cell lines to examine the potential for either human ALDH1A1 or ALDH3A1 to protect against damage mediated by these toxic aldehydes. Using crude cytosols from stably transfected cell lines, these aldehydes were confirmed to be excellent substrates for ALDH3A1, but were poorly oxidized by ALDH1A1. Expression of ALDH3A1 by stable transfection in V79 cells conferred a high level of protection against growth inhibition by the medium-chain length aldehyde substrates with highest substrate activity, including hexanal, trans-2-hexenal, trans-2-octenal, trans-2-nonenal, and 4-hydroxy-2-nonenal (HNE). This was reflected in a parallel ability of ALDH3A1 to prevent depletion of glutathione by these aldehydes. Expression of hALDH3 completely blocked the potent induction of apoptosis by HNE in both V79 cells and in a RAW 264.7 murine macrophage cell line, consistent with the observed total prevention of HNE-protein adduct formation. Structure-activity studies indicated that the rank order of potency for the contributions of HNE functional groups to toxicity was aldehyde >/=C2=C3 double bond>>C4-hydroxyl group. Oxidation of the aldehyde moiety of HNE to a carboxyl by ALDH3A1 expressed in stably transfected cell lines drastically reduced its potency for growth inhibition and apoptosis induction. In contrast, ALDH1A1 expression provided only moderate protection against trans-2-nonenal (t2NE), and none against the other six-nine carbon aldehydes. Neither ALDH1A1 nor ALDH3A1 conferred any protection against acrolein, acetaldehyde, or chloroacetaldehyde. A small degree of protection against malondialdehyde was afforded by ALDH1A1, but not ALDH3A1. Paradoxically, cells expressing ALDH3A1 were 1.5-fold more sensitive to benzaldehyde toxicity than control V79 cells. These studies demonstrate that expression of class 3 ALDH, but not class 1 ALDH, can be an important determinant of cellular resistance to toxicity mediated by aldehydes of intermediate chain length that are produced during lipid peroxidation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11306050     DOI: 10.1016/s0009-2797(00)00270-2

Source DB:  PubMed          Journal:  Chem Biol Interact        ISSN: 0009-2797            Impact factor:   5.192


  26 in total

1.  Molecular mechanisms of ALDH3A1-mediated cellular protection against 4-hydroxy-2-nonenal.

Authors:  William Black; Ying Chen; Akiko Matsumoto; David C Thompson; Natalie Lassen; Aglaia Pappa; Vasilis Vasiliou
Journal:  Free Radic Biol Med       Date:  2012-03-08       Impact factor: 7.376

2.  Human aldehyde dehydrogenase 3A1 (ALDH3A1): biochemical characterization and immunohistochemical localization in the cornea.

Authors:  Aglaia Pappa; Tia Estey; Rizwan Manzer; Donald Brown; Vasilis Vasiliou
Journal:  Biochem J       Date:  2003-12-15       Impact factor: 3.857

3.  Large contiguous gene deletions in Sjögren-Larsson syndrome.

Authors:  Holly Engelstad; Gael Carney; Dana S'aulis; Janae Rise; Warren G Sanger; M Katharine Rudd; Gabriele Richard; Christopher W Carr; Omar A Abdul-Rahman; William B Rizzo
Journal:  Mol Genet Metab       Date:  2011-05-30       Impact factor: 4.797

Review 4.  4-Hydroxy-nonenal-A Bioactive Lipid Peroxidation Product.

Authors:  Rudolf J Schaur; Werner Siems; Nikolaus Bresgen; Peter M Eckl
Journal:  Biomolecules       Date:  2015-09-30

5.  Enhanced glutathione depletion, protein adduct formation, and cytotoxicity following exposure to 4-hydroxy-2-nonenal (HNE) in cells expressing human multidrug resistance protein-1 (MRP1) together with human glutathione S-transferase-M1 (GSTM1).

Authors:  Lisa P Rudd; Sandra L Kabler; Charles S Morrow; Alan J Townsend
Journal:  Chem Biol Interact       Date:  2011-09-08       Impact factor: 5.192

6.  Oxidative and reductive metabolism of lipid-peroxidation derived carbonyls.

Authors:  Mahavir Singh; Aniruddh Kapoor; Aruni Bhatnagar
Journal:  Chem Biol Interact       Date:  2015-01-02       Impact factor: 5.192

7.  ALDH1A3 is epigenetically regulated during melanocyte transformation and is a target for melanoma treatment.

Authors:  M Pérez-Alea; K McGrail; S Sánchez-Redondo; B Ferrer; G Fournet; J Cortés; E Muñoz; J Hernandez-Losa; S Tenbaum; G Martin; R Costello; I Ceylan; V Garcia-Patos; J A Recio
Journal:  Oncogene       Date:  2017-06-05       Impact factor: 9.867

8.  Murine hepatic aldehyde dehydrogenase 1a1 is a major contributor to oxidation of aldehydes formed by lipid peroxidation.

Authors:  Ngome L Makia; Pasano Bojang; K Cameron Falkner; Daniel J Conklin; Russell A Prough
Journal:  Chem Biol Interact       Date:  2011-01-20       Impact factor: 5.192

9.  Molecular cloning and oxidative modification of human lens ALDH1A1: implication in impaired detoxification of lipid aldehydes.

Authors:  Tianlin Xiao; Mohammad Shoeb; M Saeed Siddiqui; Min Zhang; Kota V Ramana; Satish K Srivastava; Vasilis Vasiliou; Naseem H Ansari
Journal:  J Toxicol Environ Health A       Date:  2009

10.  Fat accumulation in Caenorhabditis elegans triggered by the electrophilic lipid peroxidation product 4-hydroxynonenal (4-HNE).

Authors:  Sharda P Singh; Maciej Niemczyk; Ludwika Zimniak; Piotr Zimniak
Journal:  Aging (Albany NY)       Date:  2008-12-18       Impact factor: 5.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.